Hi, thanks for the question. I did a little leg work and this is what I have found:
I spoke with a representative of Becton, Dickenson and was told that
the home diagnostics segment of the company was never a seperate
business, but merely a subsection of what was the "BD Clinical
Laboratory Solutions" wing.
Now, all of the diagnostic elements of the company are centralized in
the "BD Diagnostics" sub-company. This includes home diagnostics. The
change was simply a marketing decision to simplify the organzization.
The interworkings of the company's approach to home diagnostics has
not changed and the available home diagnostic supplies are greater now
than ever in both quantity and quality (paraphrasing the
representative with whom I spoke).
The president of this unit, BD Diagnostics, is William A. Kozy.
If you wish to follow this inquiry up and call for further
information; the phone number is-
(201) 847-6800 (New Jersey)
note: BD has acquired many smaller diagnostic companies in the past
and incorporated them into the company. It could be that you were
thinking of one of these companies. There are some details on these
accquisitions below, but first, some company information.
--------------------------------------------------------------------------------
BECTON, DICKINSON HOME PAGE:
http://www.bd.com/
from the website -- on home care:
"BD is a world leader in diabetes healthcare, providing injection
systems (insulin syringes, pens and needles) and diabetes healthcare
education to people with diabetes. BD continues to expand its presence
in retail stores through its highly recognized BD product brands for
home healthcare and sports injury treatment (e.g., ACE® bandages and
hot/cold therapy products, Bauer & Black? supports, BD? thermometers
and Tru-Fit® braces)."
BD consumer website (home care oriented):
http://www.bd.com/consumer/
Catalog of supplies:
http://catalog.bd.com/bdCat/displayTop3Categories.doCustomer?categoryID=0
------------------------------------------------------------------------------
below from;
Nelson's Public Company Profiles
Becton, Dickinson & Co.
and
Hoover's Company Profiles
2004
TICKER: BDX - EXCHANGE: NYSE
1 Becton Dr
Franklin Lakes NJ 07417-1880
United States
Telephone: 201 847-6800 Fax: 201 847-6475
2004 (LexisNexis)
They still market their diagnostic equiptment to the general public for home use:
"The Group's principal activities are to manufacture and sell
supplies, devices, laboratory equipment and diagnostic products.
Healthcare institutions, life science researchers, clinical
laboratories, industry and the public use these products."
------------------------------------------------------------------------------
FINANCIAL INFORMATION:
"MARKET CAPITAL $: 12,576,800,000
LAST YEAR REVENUE $: 3,116,900,000"
-------------------------------------------------------------------------
PERSONNEL INFORMATION:
Chairman, President, and CEO: Edward J. Ludwig, age 52, $ 1,687,397 pay
EVP and CFO: John R. Considine, age 53, $ 983,699 pay
President, BD Medical: Gary M. Cohen, age 45, $ 781,455 pay
President, BD Asia Pacific: Helen Cunniff
President, BD Biosciences: Vincent A. Forlenza, age 50, $ 695,274 pay
President, BD Europe: A. John Hanson
President, North Latin America: Laureen Higgins
President, BD Diagnostics: William A. Kozy, age 51, $ 694,959 pay
President, Japan: Rex C. Valentine
VP and Treasurer: Richard K. Berman
VP, Taxes: Mark H. Borofsky
VP, Quality Management: James R. Brown
VP, Human Resources: Jean-Marc Dageville, age 44
VP, Corporate Medical Affairs: David T. Durack
VP, Corporate Secretary and Public Policy: Dean J. Paranicas
VP, Regulatory Affairs: Patricia B. Shrader
VP and Controller: William A. Tozzi
VP and General Counsel: Jeffrey S. Sherman
CIO: Steve Sichak
Corporate Communications: Charles A. Borgognoni
-------------------------------------------------------------------------------
STOCK INFORMATION:
NO-SHAREHOLDERS: 7,007
SHARES OUTSTANDING: 252,700,000
_______________________________________________________________________________
on acquisitions of smaller diagnostic companies:
Hoover's Company Profiles
2004
"In 1996 BD introduced GlucoWatch (a glucose monitoring device
developed by Cygnus), and acquired the diagnostic business and brand
name of MicroProbe (now Epoch Pharmaceuticals). Previously known on
Wall Street as a homely company that focused on cutting costs, BD
changed its image with a string of acquisitions beginning in 1997. The
firm acquired PharMingen (biomedical research reagents) and Difco
Laboratories (microbiology media), which broadened its product lines.
BD also collaborated with Nanogen on diagnosis products for infectious
disease. In 1998 BD bought The BOC Group's medical devices business."
--------------------------------------------------------------------------------
Additional Information:
Current report on Becton, Dickinson's revenues:
Drug Week
February 27, 2004
(LexisNexis)
"Becton, Dickinson and Company (BD) (BDX) reported record revenues of
$1.2 billion for the fiscal first quarter ended December 31, 2003, an
increase of 14% from the same period a year ago.
Revenue growth in all segments benefited from favorable foreign
currency translation, particularly with respect to the Euro. Excluding
the favorable impact of foreign exchange rates, revenues increased
7%."
<<"BD's strong underlying performance was the result of solid revenue
growth and continued improvement in operating effectiveness. Sales
growth was driven, in particular, by exceptionally strong sales of
respiratory and flu diagnostic tests...>>
This notes that BD supplies diagnostic systems - including the general public:
Medical Industry Today
October 15, 1998, Thursday.
(LexisNexis)
"Becton Dickinson manufactures and sells a broad range of medical
supplies and devices and diagnostic systems for use by healthcare
professionals, medical research institutions and the general public.
For the fiscal year ended Sept. 30, 1997, Becton Dickinson had total
operating revenues of $2.8 billion and net income of $300 million.
Becton Dickinson and Co. trades on the New York Stock Exchange under
the symbol BDX."
"Becton announced Tuesday that it acquired MDI INSTRUMENTS (Woburn,
MA) for an undisclosed price to add ear fluid detection devices to its
line of home diagnostics. And on Wednesday, Becton said it is
acquiring Luther Medical, for $16.3 million, for its intellectual
property portfolio, which the company believes will enhance its
ability to offer healthcare solutions to its global customers."
Medical Industry Today
September 12, 1997
"An at-home kit to measure long-term blood glucose levels received FDA
clearance and should be welcome news for diabetics who previously
visited a laboratory or medical office to undergo the test.
The test is called B-D Easy A1C and is made by BECTON DICKINSON AND
COMPANY (Franklin Lakes, NJ). The company announced its acceptance
into the U.S. market in a release issued Thursday by PR Newswire. The
kit is expected to be made available for use in early 1998."
Medical Industry Today
February 2, 1998
<<Becton's Clateo Castellini, chairman, president and CEO said, "The
acquisition of this business is an important continuation of our
strategy to increase our growth rate and our relevance to customers by
making acquisitions that fit strategically with our businesses ...">>
________________________________________________________________________________
Search Strategy:
Lexis-Nexis Business and Industry Database
and
Google Search
"BECTON DICKINSON"
-home, diagnostic
-company information
________________________________________________________________________________
Thanks again for your question. I hope this meets your needs. Let me
know if you need any clarification.
Regards,
Anthony (adiloren-ga) |